治療性呼吸設備市場－全球產業規模、佔有率、趨勢、機會及預測（依產品類型、過濾器、技術、地區及競爭格局分類，2021-2031年）

全球治療性呼吸設備市場預計將從 2025 年的 201.1 億美元成長到 2031 年的 290.3 億美元，複合年成長率為 6.31%。

此領域涵蓋一系列旨在輔助、恢復和監測患有心肺疾病（例如氣喘、慢性阻塞性肺病(COPD) 和囊腫纖維化）患者呼吸的醫療設備。推動市場成長的關鍵因素包括全球慢性呼吸系統疾病盛行率的上升、快速都市化導致空氣品質惡化以及需要長期居家照護的老年人口不斷增加。國際藥學聯合會 (FIP) 預計，到 2024 年，全球將有 3.91 億人患有 COPD，凸顯了對有效治療方案的迫切需求。

阻礙市場擴張的主要障礙是先進技術的高成本以及不完善的報銷政策，尤其是在發展中地區。這些經濟限制往往限制了中低收入經濟體獲得維持生命和關鍵醫療設備的機會，而這些經濟體的自付醫療費用又很高。因此，終端用戶對價格的高度敏感以及醫療系統預算的緊張仍然是廣泛應用的主要障礙。

市場促進因素

都市化導致的空氣品質惡化和污染水平上升是全球呼吸治療設備市場的主要促進因素。工業活動和汽車廢氣排放的增加導致顆粒物濃度升高，加劇了氣喘和慢性阻塞性肺病（COPD）等慢性呼吸系統疾病，迫使醫療保健提供者開立各種治療方法，從霧化器到氧氣濃縮器。根據美國肺臟協會2024年4月發布的《空氣狀況》報告，美國約有1.312億人居住在臭氧或顆粒物污染嚴重的地區，凸顯了普及呼吸支持系統以應對空氣污染對健康影響的緊迫性。

此外，智慧型攜帶式呼吸設備的科技創新推動了市場成長，促進了居家照護和遠端患者監護的發展。現代設備具備互聯功能，使臨床醫生能夠即時追蹤患者的依從性和生理數據，從而改善治療效果並降低再入院率。 ResMed公司2024年年度報告顯示，該公司在全球支援超過2,600萬台雲端連接設備，充分展現了數位化應用的廣泛程度。這種整合不僅提升了患者照護，也創造了顯著的經濟效益，Fisher & Paykel Healthcare公司2024年5月錄得的17.4億紐西蘭元營業收入便印證了這一點。

市場挑戰

先進技術的高成本和不完善的報銷體係是限制全球呼吸治療設備市場成長的重要經濟障礙。製造商在開發先進生命維持系統方面投入了大量研發成本，這增加了設備所需的資本支出。在許多中低收入國家，醫療機構面臨嚴格的預算限制，即使臨床需要，也難以採用昂貴的技術。這種資金缺口迫使醫院推遲設備升級或繼續使用過時、效率低下的型號，從而延緩了現代治療方案的採用，並限制了製造商的市場擴張。

這種價格差異導致需要治療的患者人數與實際接受治療的設備數量之間有顯著脫節。儘管市場潛力巨大，但由於患者和醫療服務提供者無法負擔高昂的自付費用，臨床需求仍落後於收入成長。這種錯失良機的規模在高危險群中顯而易見。根據美國肺臟協會2024年的報告，美國約有1.312億人居住在臭氧和顆粒物污染水平對其健康有害的地區。由於缺乏足夠的報銷模式來抵消治療費用，這部分弱勢群體中的很大一部分仍然難以獲得經濟效益，從而限制了整體市場的擴張。

市場趨勢

隨著製造商向低碳技術轉型，永續和可重複使用設備的設計正在重塑市場格局。各公司正致力於重新設計定量噴霧吸入器，採用全球暖化潛勢值（GWP）接近零的推進劑，以在維持臨床療效的同時，減少產業的環境足跡。例如，《永續發展雜誌》在2025年5月報道稱，阿斯特捷利康公司獲得了英國監管機構的核准，其首款採用GWP接近於零的新一代推進劑的吸入式呼吸治療產品正式上市，這標誌著永續醫療創新邁出了重要一步。

此外，人工智慧 (AI) 在預測性呼吸分析中的應用，正將該領域從被動治療轉變為預防性護理。機器學習演算法現已用於分析生理數據並預測症狀惡化，使臨床醫生能夠更早進行干預，預防急性緊急情況的發生。這種方法透過減少可預防的住院治療來提高病人安全，並減輕經濟負擔。赫爾大學教學醫院 2024 年 12 月發布的一份報告強調，引入人工智慧驅動的 Lenus COPD 支援服務使慢性呼吸系統疾病患者的再入院率降低了 40%。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球治療性呼吸設備市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品類型（霧化器、加濕器、氧氣濃縮機、人工呼吸器、二氧化碳測量儀、氣體分析儀）
  • 依過濾器類型（霧化器過濾器、加濕器過濾器、正壓呼吸器過濾器、氧氣濃縮機過濾器、人工呼吸器過濾器）
  • 依技術分類（靜電過濾、HEPA過濾技術、中空纖維過濾、微球分離）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美治療性呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲治療性呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區呼吸治療設備市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲治療性呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲治療性呼吸設備市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

13. 全球治療性呼吸設備市場：SWOT 分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• ResMed Inc.
• Medtronic plc
• Koninklijke Philips NV
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Dragerwerk AG & Co. KGaA
• Teleflex Incorporated
• Hamilton Medical AG
• Invacare Corporation
• CAIRE Inc.
• Nihon Kohden Corporation
• Inogen Inc.
• Masimo Corporation
• Chart Industries
• Compumedics Limited
• VitalAir

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Therapeutic Respiratory Devices Market is projected to expand from USD 20.11 Billion in 2025 to USD 29.03 Billion by 2031, registering a CAGR of 6.31%. This sector covers a wide array of medical equipment intended to assist, restore, and monitor breathing in patients with cardiopulmonary disorders like asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Key factors driving market growth include the rising global prevalence of chronic respiratory conditions, declining air quality linked to rapid urbanization, and an increasing geriatric population necessitating long-term home care. In 2024, the International Pharmaceutical Federation estimated that 391 million people worldwide were living with COPD, highlighting the critical need for effective therapeutic solutions.

A major obstacle potentially hindering market expansion is the high cost of advanced technologies coupled with insufficient reimbursement policies, particularly in developing regions. These financial constraints often limit access to vital life-support and maintenance equipment in low-to-middle-income economies where out-of-pocket healthcare costs are substantial. As a result, price sensitivity among end-users and strict budgetary limitations within healthcare systems remain significant barriers to widespread adoption.

Market Driver

Declining ambient air quality and escalating pollution levels resulting from urbanization serve as primary drivers for the Global Therapeutic Respiratory Devices Market. As industrial activities and vehicular emissions increase, higher concentrations of particulate matter exacerbate chronic respiratory conditions like asthma and COPD, compelling healthcare providers to prescribe interventions ranging from nebulizers to oxygen concentrators. According to the American Lung Association's 'State of the Air' report in April 2024, approximately 131.2 million individuals in the United States lived in counties with failing grades for ozone or particle pollution, underscoring the urgent need for accessible respiratory support systems to manage the health effects of poor air quality.

Furthermore, technological innovations in smart and portable respiratory devices are accelerating market growth by enabling a shift toward home-based care and remote patient monitoring. Contemporary devices feature connectivity that allows clinicians to track patient adherence and physiological data in real-time, thereby improving treatment outcomes and decreasing hospital readmissions. ResMed Inc.'s 2024 Annual Report noted that the company supports over 26 million cloud-connected devices globally, illustrating the vast scale of digital adoption. This integration enhances patient care and generates significant economic activity, as evidenced by Fisher & Paykel Healthcare's report of record operating revenue of NZ$1.74 billion in May 2024.

Market Challenge

The high cost of advanced technologies and inadequate reimbursement frameworks create a significant economic barrier that impedes the growth of the global therapeutic respiratory devices market. Manufacturers invest substantially in research and development to create sophisticated life-support systems, which increases the capital expenditure required for these devices. In many low-to-middle-income economies, healthcare facilities operate under tight budget constraints, rendering them unable to purchase premium technologies despite the clinical need. This financial disconnect compels hospitals to delay upgrades or utilize older, less efficient models, thereby stalling the adoption of modern therapeutic solutions and limiting the market reach for manufacturers.

This pricing disparity results in a considerable gap between the volume of patients needing care and the actual deployment of therapeutic devices. Although the market potential is vast, the inability of patients and providers to manage high out-of-pocket costs limits the conversion of clinical demand into revenue growth. The scale of this missed opportunity is evident in the population at risk; the American Lung Association reported in 2024 that roughly 131.2 million people in the United States lived in areas with unhealthy levels of ozone or particle pollution. Without sufficient reimbursement models to offset treatment costs, a large portion of this vulnerable demographic remains difficult to monetize, restricting overall market expansion.

Market Trends

The market is being reshaped by the adoption of sustainable and reusable device designs as manufacturers shift toward low-carbon technologies. Companies are focusing on reformulating metered-dose inhalers with propellants that have near-zero global warming potential (GWP) to reduce the sector's environmental footprint while preserving clinical efficacy. For instance, Sustainability Magazine reported in May 2025 that AstraZeneca received UK regulatory approval for the first inhaled respiratory medicine utilizing a next-generation propellant with near-zero GWP, marking a significant step in sustainable healthcare innovation.

Additionally, the integration of artificial intelligence for predictive respiratory analytics is transforming the sector from reactive treatment to proactive care. Machine learning algorithms are now utilized to analyze physiological data to forecast exacerbations, enabling clinicians to intervene early and prevent acute emergencies. This approach enhances patient safety and reduces financial burdens by decreasing preventable hospitalizations. A report by Hull University Teaching Hospitals in December 2024 highlighted that the deployment of the AI-enabled Lenus COPD support service resulted in a 40% reduction in hospital readmissions for patients with chronic respiratory conditions.

Key Market Players

• ResMed Inc.
• Medtronic plc
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Limited
• GE Healthcare
• Dragerwerk AG & Co. KGaA
• Teleflex Incorporated
• Hamilton Medical AG
• Invacare Corporation
• CAIRE Inc.
• Nihon Kohden Corporation
• Inogen Inc.
• Masimo Corporation
• Chart Industries
• Compumedics Limited
• VitalAir

Report Scope

In this report, the Global Therapeutic Respiratory Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Therapeutic Respiratory Devices Market, By Product Type

• Nebulizers
• Humidifiers
• Oxygen Concentrators
• Positive Airway Pressure Devices
• Ventilators
• Capnographs
• Gas Analyzers

Therapeutic Respiratory Devices Market, By Filter

• Nebulizer filters
• Humidifier filters
• Positive airway pressure devices filter
• Oxygen concentrator filters
• Ventilator filters

Therapeutic Respiratory Devices Market, By Technology

• Electrostatic Filtration
• HEPA Filter Technology
• Hollow Fiber Filtration
• Microsphere Separation

Therapeutic Respiratory Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Therapeutic Respiratory Devices Market.

Available Customizations:

Global Therapeutic Respiratory Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Therapeutic Respiratory Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers)
  • 5.2.2. By Filter (Nebulizer filters, Humidifier filters, Positive airway pressure devices filter, Oxygen concentrator filters, Ventilator filters)
  • 5.2.3. By Technology (Electrostatic Filtration, HEPA Filter Technology, Hollow Fiber Filtration, Microsphere Separation)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Therapeutic Respiratory Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Filter
  • 6.2.3. By Technology
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Therapeutic Respiratory Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Filter
      • 6.3.1.2.3. By Technology
  • 6.3.2. Canada Therapeutic Respiratory Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Filter
      • 6.3.2.2.3. By Technology
  • 6.3.3. Mexico Therapeutic Respiratory Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Filter
      • 6.3.3.2.3. By Technology

7. Europe Therapeutic Respiratory Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Filter
  • 7.2.3. By Technology
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Therapeutic Respiratory Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Filter
      • 7.3.1.2.3. By Technology
  • 7.3.2. France Therapeutic Respiratory Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Filter
      • 7.3.2.2.3. By Technology
  • 7.3.3. United Kingdom Therapeutic Respiratory Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Filter
      • 7.3.3.2.3. By Technology
  • 7.3.4. Italy Therapeutic Respiratory Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Filter
      • 7.3.4.2.3. By Technology
  • 7.3.5. Spain Therapeutic Respiratory Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Filter
      • 7.3.5.2.3. By Technology

8. Asia Pacific Therapeutic Respiratory Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Filter
  • 8.2.3. By Technology
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Therapeutic Respiratory Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Filter
      • 8.3.1.2.3. By Technology
  • 8.3.2. India Therapeutic Respiratory Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Filter
      • 8.3.2.2.3. By Technology
  • 8.3.3. Japan Therapeutic Respiratory Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Filter
      • 8.3.3.2.3. By Technology
  • 8.3.4. South Korea Therapeutic Respiratory Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Filter
      • 8.3.4.2.3. By Technology
  • 8.3.5. Australia Therapeutic Respiratory Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Filter
      • 8.3.5.2.3. By Technology

9. Middle East & Africa Therapeutic Respiratory Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Filter
  • 9.2.3. By Technology
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Therapeutic Respiratory Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Filter
      • 9.3.1.2.3. By Technology
  • 9.3.2. UAE Therapeutic Respiratory Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Filter
      • 9.3.2.2.3. By Technology
  • 9.3.3. South Africa Therapeutic Respiratory Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Filter
      • 9.3.3.2.3. By Technology

10. South America Therapeutic Respiratory Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Filter
  • 10.2.3. By Technology
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Therapeutic Respiratory Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Filter
      • 10.3.1.2.3. By Technology
  • 10.3.2. Colombia Therapeutic Respiratory Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Filter
      • 10.3.2.2.3. By Technology
  • 10.3.3. Argentina Therapeutic Respiratory Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Filter
      • 10.3.3.2.3. By Technology

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Therapeutic Respiratory Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. ResMed Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc
• 15.3. Koninklijke Philips N.V.
• 15.4. Fisher & Paykel Healthcare Limited
• 15.5. GE Healthcare
• 15.6. Dragerwerk AG & Co. KGaA
• 15.7. Teleflex Incorporated
• 15.8. Hamilton Medical AG
• 15.9. Invacare Corporation
• 15.10. CAIRE Inc.
• 15.11. Nihon Kohden Corporation
• 15.12. Inogen Inc.
• 15.13. Masimo Corporation
• 15.14. Chart Industries
• 15.15. Compumedics Limited
• 15.16. VitalAir

16. Strategic Recommendations

17. About Us & Disclaimer